Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001048477-23-000074
Filing Date
2023-12-28
Accepted
2023-12-28 13:15:49
Documents
3
Period of Report
2023-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1703787340.html 3  
1 FORM 3 wk-form3_1703787340.xml 3 1605
2 EX-24 section16filingspowerofa.htm EX-24 4068
3 section16filingspowerofa001.jpg GRAPHIC 238773
  Complete submission text file 0001048477-23-000074.txt   336067
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DENTSPLY SIRONA INC 13320 BALLANTYNE CORPORATE PLACE CHARLOTTE NC 28277
Business Address
Bodem Barbara W. (Reporting) CIK: 0001713893 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26727 | Film No.: 231521414